Assignee profile:

N.V. INNOGENETICS S.A.

City:

Ghent

Country:

Belgium

Published Applications:

10

Last publication date:

2009-05-28

Patent Grants:

8

Last grant date:

2012-04-24

Top Inventors for applications by N.V. INNOGENETICS S.A.

These are the the leading inventors for applications assigned to N.V. INNOGENETICS S.A.:

Recent patent applications by N.V. INNOGENETICS S.A.

N.V. INNOGENETICS S.A. based in Ghent, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2009-05-28 ✅ Patent 8,163,873 granted on 2012-04-24
US20090137051A1
Physics

Isolated microtubule-associated protein tau peptides and kit

#2 | 2007-10-18 ✅ Patent 7,855,052 granted on 2010-12-21
US20070243524A1
Chemistry; metallurgy

Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents

#3 | 2007-08-14 ✅ Patent 7,255,997 granted on 2007-08-14
US9638693
-

Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents

#4 | 2007-03-27 ✅ Patent 7,195,765 granted on 2007-03-27
US9899046
-

Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents

#5 | 2006-10-17 ✅ Patent 7,122,306 granted on 2006-10-17
US9873224
-

Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents

#6 | 2006-08-01 ✅ Patent 7,083,797 granted on 2006-08-01
US10329087
-

32-kDa protein derived from and related peptides

#7 | 2006-04-13
US20060078932A1
Chemistry; metallurgy

Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes

#8 | 2006-01-12
US20060008853A1
Physics

Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same

#9 | 2005-05-31 ✅ Patent 6,900,293 granted on 2005-05-31
US9734281
-

Monoclonal antibodies directed against the microtubule-associated protein tau

#10 | 2005-02-15 ✅ Patent 6,855,318 granted on 2005-02-15
US9566266
-

Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes

AssigneeID:

285692 ⎘